Conference
A Randomized Phase Ii Trial of Selumetinib plus Platinum-pemetrexed (Pem-c) in Kras Wildtype (Wt)/Unknown NSCLC: CCTG Ind219
Authors
Bradbury P; Melosky B; Tu D; Nicholas G; Wheatley-Price P; Laurie S; Goss G; Florescu M; Basappa N; Reiman A
Volume
12
Pagination
pp. S2080-S2080
Publisher
ELSEVIER SCIENCE INC
Publication Date
November 1, 2017
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
Issue
11
ISSN
1556-0864